Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trials Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 57.76 billion in 2023, and the market is now projected to grow from USD 61.58 billion in 2024 to USD 106.78 billion by 2032, exhibiting a CAGR of 7.1% during the forecast period of 2024-2032. ... Read More
-
2024 Global Forecast for Eclinical Solutions Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Clinical Laboratory Service Market Size Study & Forecast, By Test Type (Genetic Testing, Clinical Chemistry, Medical Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Drug of Abuse Testing. Other Esoteric Tests) By Service Provider (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), By Application (Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services, Other Clinical Laboratory Services) and Regional Analysis, 2023-2030
... (Hospital-based Laboratories, Stand-alone Laboratories, Clinic-based Laboratories), By Application (Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, Drug Discovery & Development Related Services, Other ... Read More
-
2024 Global Forecast for Electronic Clinical Outcome Assessment Solutions Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
Global Drug Screening Databank Market Report
... 2031. Drug Screening Service segment is expected to be the highest contributor to this market, with $2,091.3 Million in 2022, and is anticipated to reach $5,840.6 Million by 2031, registering a CAGR of 12.15%. Drug ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
... from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. ... Read More
-
Global Cell And Gene Therapy Clinical Trials Databank Market Report
... at a CAGR of 6.20% from 2021 to 2029. Cardiology segment is expected to be the highest contributor to this market, with $9,361.8 Million in 2020, and is anticipated to reach $16,753.6 Million by 2029, ... Read More
-
Global In Silico Clinical Trials Databank Market Report
... 5.99% from 2023 to 2031. Medical Devices segment is expected to be the highest contributor to this market, with $1,461.1 Million in 2022, and is anticipated to reach $2,538.7 Million by 2031, registering a CAGR ... Read More
-
Global Investigational Drug CDMO Databank Market Report
... 2023 to 2031. Small Molecule segment is expected to be the highest contributor to this market, with $3,991.1 Million in 2022, and is anticipated to reach $6,166.8 Million by 2031, registering a CAGR of 5.00%. ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
... 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be the highest contributor to this market, with $1,304.4 Million in 2020, and is anticipated to reach $3,116.3 Million by 2029, registering a CAGR ... Read More
-
Post-operative Pain (POP) - Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for POP. Most marketed drugs for POP are enzyme inhibitors, followed by receptor agonists, by mechanism of action. Phase III pipeline for POP is robust and includes ... Read More
-
Friedreich Ataxia (FRDA) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for FRDA. The marketed drugs space for FRDA is limited to just two approved drugs, Biogen's Skyclarys (omaveloxolone) is the leading drug in FRDA space. R&D ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Epilepsy - Global Clinical Trials Review, 2024
... the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Pulmonary Tuberculosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024
... Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Juvenile Macular Degeneration (Stargardt Disease). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Decompensated Cirrhosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Decompensated Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024
... / Exudative) Macular Degeneration Clinical trials scenario. This report provides top line data relating to the clinical trials on Wet (Neovascular / Exudative) Macular Degeneration. Report includes an overview of trial numbers and their average ... Read More
-
Amyloidosis - Global Clinical Trials Review, 2024
... the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Global Clinical Trial Management System Market Report and Forecast 2024-2032
... USD 1.5 billion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 12.48% from 2017 to 2032, reaching a value of USD 4.3 billion by 2032. A CTMS is ... Read More
-
Duchenne Muscular Dystrophy Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... to reach USD 4.32 billion by 2029, growing at a CAGR of 11.10% during the forecast period (2024-2029). The outbreak of COVID-19 impacted the market. The pandemic increased the incidence rate of Duchenne muscular dystrophy. ... Read More
-
Regulatory Reporting and Compliance Market Size, Trends, Analysis, and Outlook By Type (Regulatory Consulting, Product Registration and Clinical Trials, Legal Representation, Regulatory Writing and Publishing, Others), By Service Provider (In-House, Out-Sourcing), By End-User (Pharmaceuticals Companies, Medical Devices Companies, Biotechnology Companies), by Country, Segment, and Companies, 2024-2032
... Medical Devices Companies, Biotechnology Companies), by Country, Segment, and Companies, 2024-2032 The global Regulatory Reporting and Compliance market size is poised to register 13.6% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
Research Assistance
